Skip to content

Repeatability and Stability of Healthy Skin Features on OCT

Assessing the Stability and Repeatability of OCT Features in Healthy Skin: a Test-retest Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05517889
Enrollment
20
Registered
2022-08-26
Start date
2022-09-01
Completion date
2023-12-31
Last updated
2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Optical Coherence Tomography, Radiomics

Keywords

Optical coherence tomography, OCT, Artificial intelligence, AI, Radiomics, Test-retest, Imaging, Dermatology, Skin

Brief summary

A test-retest study on the stability and repeatability of healthy skin features on OCT

Interventions

DIAGNOSTIC_TESTOptical coherence tomography

Optical coherence tomography is a non-invasive scanner which generates real-time in-vivo images of the skin and its adnexal structures. Images are generated by light-interferometry.

Sponsors

Maastricht University (Precision medicine The D-lab)
CollaboratorUNKNOWN
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least18 years of age

Exclusion criteria

* Unable to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Repeatable hand-crafted radiomics-featuresInterval of 10 minutesThe number of HRFs that are repeatable in a test-retest setting
Interclass Correlation Coefficient (ICC)1 monthIntraclass Correlation Coefficient (ICC) will be used to assess the correlation and repeatability of the HRFs resulting from OCT scans. ICC will be calculated after all scans have been obtained. ICC will be used to rank the HRFs. This statistical test is commonly used reliability index in test re-test studies.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026